US OptionsDetailed Quotes
NVO241129C107000
- 0.31
- -0.38-55.07%
15min DelayClose Nov 27 16:00 ET
0.46High0.18Low
0.43Open0.69Pre Close136 Volume259 Open Interest107.00Strike Price4.08KTurnover25.71%IV1.11%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.31Extrinsic Value100Contract SizeAmericanOptions Type0.3027Delta0.2153Gamma342.35Leverage Ratio-0.2595Theta0.0011Rho103.63Eff Leverage0.0220Vega
Novo-Nordisk A/S Stock Discussion
The Commission concluded that the notified transaction would not raise competition concerns, given that the joint ventu...
Gapping up
$Poseida Therapeutics (PSTX.US)$' stock jumped over 200%. This happened because Roche, a Swiss company, is buying Poseida for up to $1.5 billion in cash.
Shares of weight-loss drug maker $Novo-Nordisk A/S (NVO.US)$ and $Eli Lilly and Co (LLY.US)$ rose 2.1% and 4.9% respectively on Tuesday as U.S. President Jo Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid...
New Positions
$Taiwan Semiconductor (TSM.US)$ , $Broadcom (AVGO.US)$ , $Johnson & Johnson (JNJ.US)$ , $Pfizer (PFE.US)$ , $Coca-Cola (KO.US)$ , $Occidental Petroleum (OXY.US)$
Sold out Positions
$Disney (DIS.US)$
Increased Positions
$Novo-Nordisk A/S (NVO.US)$ , $AstraZeneca (AZN.US)$ , $Huntington Ingalls Industries (HII.US)$
Decreased Positions
None
loading...
No comment yet